{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:50:42Z","timestamp":1775901042422,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.026","type":"journal-article","created":{"date-parts":[[2011,8,19]],"date-time":"2011-08-19T17:28:17Z","timestamp":1313774897000},"page":"8126-8133","source":"Crossref","is-referenced-by-count":133,"title":["Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis"],"prefix":"10.1016","volume":"29","author":[{"given":"Vesna","family":"Blazevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvi","family":"Lappalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsi","family":"Nurminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Huhti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Vesikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.08.026_bib0005","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMra0804575","article-title":"Norovirus gastroenteritis","volume":"361","author":"Glass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0010","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3201\/eid1408.071114","article-title":"Systematic literature review of role of noroviruses in sporadic gastroenteritis","volume":"14","author":"Patel","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcv.2009.09.010","article-title":"Differences in clinical presentation between norovirus genotypes in nursing homes","volume":"46","author":"Friesema","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0255","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jir039","article-title":"Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children","volume":"203","author":"Huhti","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0025","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0030","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1128\/JVI.72.2.1345-1353.1998","article-title":"Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice","volume":"72","author":"Ball","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0035","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1128\/JVI.75.20.9713-9722.2001","article-title":"Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses","volume":"75","author":"Guerrero","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0040","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.0901540","article-title":"Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles","volume":"184","author":"Keller","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0055","first-page":"1787","article-title":"Rotaviruses","volume":"vol. 2","author":"Kapikian","year":"2001"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/viro.1997.8762","article-title":"Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis","volume":"237","author":"Tang","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0065","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1128\/JVI.61.5.1488-1494.1987","article-title":"Synthesis and immunogenicity of the rotavirus major capsid antigen using a baculovirus expression system","volume":"61","author":"Estes","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0070","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/JCM.34.7.1694-1700.1996","article-title":"Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice","volume":"34","author":"Ishida","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0075","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.vaccine.2005.12.048","article-title":"Immunity and correlates of protection for rotavirus vaccines","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1692","article-title":"Rotavirus vaccines: recent developments and future considerations","volume":"5","author":"Angel","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0085","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/emboj\/20.7.1498","article-title":"Structural polymorphism of the major capsid protein of rotavirus","volume":"20","author":"Lepault","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0090","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/S0264-410X(03)00308-6","article-title":"Immunogenicity and protective efficacy of rotavirus 2\/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice","volume":"21","author":"Bertolotti-Ciarlet","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0095","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007050050674","article-title":"The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response","volume":"145","author":"Esquivel","year":"2000","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0100","doi-asserted-by":"crossref","first-page":"11574","DOI":"10.1128\/JVI.74.24.11574-11580.2000","article-title":"Functional mapping of protective domains and epitopes in the rotavirus VP6 protein","volume":"74","author":"Choi","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/JVI.76.2.560-568.2002","article-title":"CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)","volume":"76","author":"McNeal","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0110","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1128\/JVI.73.9.7574-7581.1999","article-title":"Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein","volume":"73","author":"Choi","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0115","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1016\/j.vaccine.2007.05.065","article-title":"Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge","volume":"25","author":"McNeal","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0120","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1128\/JVI.72.11.9233-9246.1998","article-title":"Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity","volume":"72","author":"Ciarlet","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0125","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1128\/JVI.74.19.8843-8853.2000","article-title":"Intranasal administration of 2\/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs","volume":"74","author":"Yuan","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0135","unstructured":"Centers for Disease Control and Prevention. Statement regarding Rotarix\u00ae and RotaTeq\u00ae rotavirus vaccines and intussusception. Available from: http:\/\/www.cdc.gov\/vaccines\/vpd-vac\/rotavirus\/intussusception-studies-acip.htm [accessed 17.11.2010]."},{"key":"10.1016\/j.vaccine.2011.08.026_bib0140","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02690-09","article-title":"Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus","volume":"84","author":"Victoria","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0145","unstructured":"Food and Drug Administration. Vaccines and related biological products advisory committee meeting background material. Porcine circovirus and rotavirus vaccines. Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm211101.htm [accessed 10.1.2011]."},{"key":"10.1016\/j.vaccine.2011.08.026_bib0150","doi-asserted-by":"crossref","unstructured":"Koho T, Huhti L, Blazevic V, Nurminen K, Butcher S, Laurinm\u00e4ki P, et al. Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus. J Virol Methods, in press.","DOI":"10.1016\/j.jviromet.2011.05.009"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0155","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/JCM.40.8.2854-2859.2002","article-title":"Molecular epidemiology of caliciviruses causing outbreaks and sporadic cases of acute gastroenteritis in Spain","volume":"40","author":"Buesa","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0160","doi-asserted-by":"crossref","unstructured":"Puustinen L, Blazevic V, Salminen M, H\u00e4m\u00e4l\u00e4inen M, R\u00e4s\u00e4nen S, Vesikari T. Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009\u20132010. Scand J Infect Dis, in press.","DOI":"10.3109\/00365548.2011.588610"},{"issue":"April","key":"10.1016\/j.vaccine.2011.08.026_bib0165","first-page":"1","article-title":"Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007","volume":"14","author":"Puustinen","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0170","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00705-010-0768-z","article-title":"A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles","volume":"155","author":"Huhti","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/00365548.2010.508462","article-title":"Rotavirus gastroenteritis in Finnish children in 2006\u20132008, at the introduction of rotavirus vaccination","volume":"46","author":"R\u00e4s\u00e4nen","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0180","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1128\/JVI.80.8.3801-3810.2006","article-title":"Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30\/96 provides evidence for interspecies transmission","volume":"80","author":"Matthijnssens","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0185","doi-asserted-by":"crossref","first-page":"11010","DOI":"10.1128\/JVI.75.22.11010-11016.2001","article-title":"Rotavirus 2\/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1\/Th2-like immune response","volume":"75","author":"Fromantin","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jmv.21990","article-title":"Prevalence of norovirus GII-4 antibodies in Finnish children","volume":"83","author":"Nurminen","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JVI.01835-10","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","author":"Tan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jmv.20473","article-title":"Characterization of the homo- and heterotypic immune responses after natural norovirus infection","volume":"77","author":"Rockx","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0205","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0210","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/129.6.709","article-title":"Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers","volume":"129","author":"Wyatt","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0215","doi-asserted-by":"crossref","first-page":"e2954","DOI":"10.1371\/journal.pone.0002954","article-title":"Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine","volume":"3","author":"Makidon","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0220","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2006.03.080","article-title":"Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains","volume":"24","author":"LoBue","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0225","series-title":"Fourth International Conference on Caliciviruses","article-title":"A paradigm shift in norovirus outbreaks: the emergence of II.12 strains as a major contributor to disease","author":"Vega","year":"2010"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0230","doi-asserted-by":"crossref","first-page":"12335","DOI":"10.1128\/JVI.76.23.12335-12343.2002","article-title":"Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0235","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/gast.2002.33661","article-title":"Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals","volume":"122","author":"Marionneau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0240","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0245","doi-asserted-by":"crossref","unstructured":"R\u00e4s\u00e4nen S, Lappalainen S, Salminen M, Huhti L, Vesikari T. Noroviruses in children seen in a hospital for acute gastroenteritis in Finland. Eur J Pediatr, in press.","DOI":"10.1007\/s00431-011-1443-4"},{"key":"10.1016\/j.vaccine.2011.08.026_bib0250","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/431512","article-title":"More on RotaShield and intussusception: the role of age at the time of vaccination","volume":"192","author":"Simonsen","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11012552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T12:31:02Z","timestamp":1592829062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11012552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":50,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11012552"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}